Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

15421 - 15430 of 51504 results found

Controlling infections in hospitalized pretransplant candidates

Date
Wednesday, November 22, 2023 - 4:00 AM
Description
PURPOSE OF REVIEW: Infections in hospitalized patients awaiting solid organ transplantation can pose complicated diagnostic and therapeutic challenges. Goals of management include stabilizing the patient, treating or controlling infections, and

Has the Use of the Mask Exacerbated Rosacea During the Pandemic?

Date
Wednesday, November 22, 2023 - 4:00 AM
Description
CONCLUSIONS: We did not find a significant increase in relapses of papulopustular rosacea during the pandemic. An appropriate anti-parasitic treatment may reduce the number of recurrences due to mask use.

Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability

Date
Wednesday, November 22, 2023 - 4:00 AM
Description
The ongoing transmission of SARS-CoV-2 necessitates the development of additional potent antiviral agents capable of combating the current highly infectious variants and future coronaviruses. Here, we present the discovery of potent nonpeptide main

Stress and headaches in university students during the COVID-19 pandemic

Date
Wednesday, November 22, 2023 - 4:00 AM
Description
With regards to the relationship between mental and physical health conditions, some studies predict increased headache frequency as a result of exposure to stressful situations. Thus, the purpose of our study was to investigate whether headache

Immune imprinting as a barrier to effective COVID-19 vaccines

Date
Wednesday, November 22, 2023 - 4:00 AM
Description
Wang and colleagues show that immune imprinting impairs neutralizing antibody titers for bivalent mRNA vaccination against SARS-CoV-2 Omicron subvariants. Imprinting from three doses of monovalent vaccine can be alleviated by BA.5 or BQ-lineage